Mylan

analuisa-gamboa-WsTP_d3VEgk-unsplash

In India, Drugs for COVID Are Being Tested, Approved in Ways That Should Worry Us

Ronak Borana 25/05/2021

Many COVID-19-related clinical trials have several methodological flaws, and...

2019-08-08T143854Z_1_LYNXNPEF771CW_RTROPTP_4_USA-FDA-NOVARTIS

Pharma Firm Mylan Under FDA Scanner Over Quality Issues at Telangana Plant

The Wire Staff 02/09/2020

The drug regulator found the plant hadn’t taken the...

FILE PHOTO: An ampule of Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg

Generic Version of Remdesivir to Be Launched in India at Rs 4,800 per 100 mg Vial

Reuters 06/07/2020

Mylan's version comes after two Indian drugmakers, Cipla Ltd...

download (15) (1)

Watch | COVID-19 Updates: Jubilant Life Sciences Among Companies to Manufacture & Sell Remdesivir in India

Pawanjot Kaur 13/05/2020

Earlier this month, remdesivir was given emergency use authorisation...

Screenshot-2019-03-02-at-11.05.45-AM

Indian Pharma Firm Complains About Documentary; Dutch Council Stands by It

Anoo Bhuyan 01/03/2019

The council said that it “does not share” Aurobindo’s...

A health technician analyses blood samples for tuberculosis testing in a high-tech tuberculosis lab in Carabayllo in Lima, Peru May 19, 2016. Credit: Reuters

Only Handful in India Will Have Access to TB ‘Wonder Drug’ Delamanid Next Month

Disha Shetty 13/07/2018

Four-hundred doses of Delamanid, one of the last known...